AIM ImmunoTech Balance Sheet (2010-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Assets
Current Assets
Cash & Equivalents (Quarter)	37.35M	32.09M	28.99M	34.45M	29.76M	27.05M	23.39M	21.04M	15.26M	5.44M	3.29M	3.55M	0.92M	1.70M	0.90M	0.48M	2.35M	2.98M	5.82M	9.90M
Short-term Investments (Quarter)	16.51M	16.18M		7.32M	6.99M	7.14M	7.45M	7.36M	7.17M	7.63M	7.65M	6.51M	6.29M	8.24M	1.35M	0.36M	0.06M	0.06M	0.06M	0.06M
Cash & Current Investments (Quarter)	53.86M	48.27M	28.99M	41.77M	36.74M	34.19M	30.85M	28.40M	22.43M	13.07M	10.94M	10.06M	7.20M	9.95M	2.25M	0.83M	2.41M	3.05M	5.88M	9.96M
Receivables - Net (Quarter)	0.03M					1.68M	1.76M	0.03M	0.05M	1.18M								0.01M
Receivables - Other (Quarter)		1.64M	1.64M			1.68M			1.69M						0.02M				-0.01M
Receivables (Quarter)	0.03M					3.35M	1.76M	0.03M	1.73M	1.18M								0.01M
Work In Process (Quarter)
Prepaid Assets (Quarter)	0.16M	0.30M	0.30M	0.37M	0.81M	0.46M	0.55M	0.44M	0.26M	0.30M	0.36M	0.30M	0.37M	0.20M	0.32M	0.19M	0.17M	0.24M	0.34M	0.47M
Current Assets (Quarter)	38.04M	50.21M	50.38M	46.05M	41.15M	36.32M	33.16M	28.87M	22.74M	14.56M	11.31M	10.36M	7.57M	4.18M	2.58M	1.02M	2.58M	3.29M	6.21M	10.43M
Non-Current Assets
Construction in Progress (Quarter)
Land & Improvements (Quarter)	10.53M	3.90M
Property, Plant & Equipment (Net) (Quarter)	5.99M	4.05M	0.14M	0.13M	0.12M	0.20M	0.15M	0.14M	0.14M	0.13M	0.12M	0.11M	0.12M	0.11M	0.10M	0.09M	0.08M	0.07M	0.06M	0.05M
Long-Term Investments (Quarter)	15.81M
Intangibles (Quarter)	0.44M	1.97M	0.03M	2.01M	0.10M	1.94M	1.90M	2.04M	2.15M	2.31M	0.05M	0.28M	0.42M	2.59M	2.27M	0.28M	2.99M	2.33M	0.04M	0.15M
Goodwill & Intangibles (Quarter)	0.44M	1.97M	0.03M	2.01M	0.10M	1.94M	1.90M	2.04M	2.15M	2.31M	0.05M	0.28M	0.42M	2.59M	2.27M	0.28M	2.99M	2.33M	0.04M	0.15M
Long-Term Deferred Tax (Quarter)
Other Non-Current Assets (Quarter)	1.25M	1.32M	1.51M	1.81M	2.14M	1.20M	1.46M	1.78M	2.10M	1.69M	1.69M	2.05M	2.72M	1.11M	0.74M	0.35M	0.36M	0.38M	0.33M	0.27M
Non-Current Assets (Quarter)	25.04M	7.49M	3.77M	4.84M	5.13M	4.17M	4.30M	4.75M	5.12M	4.83M	4.88M	5.35M	6.02M	4.43M	3.66M	3.10M	2.92M	2.49M	2.37M	2.30M
Assets (Quarter)	63.08M	57.70M	54.16M	50.88M	46.28M	40.49M	37.46M	33.62M	27.86M	19.38M	16.19M	15.71M	13.59M	8.61M	6.25M	4.13M	5.49M	5.78M	8.59M	12.73M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	0.37M	0.20M	0.38M	0.71M	0.96M	0.38M	0.96M	2.15M	2.79M	6.44M	6.57M	5.46M	6.26M	6.38M	6.94M	7.30M	1.25M	1.63M	1.22M	0.48M
Notes Payables (Quarter)											1.62M	2.35M	2.59M	2.31M	1.95M	2.29M	1.88M	3.55M	4.00M	3.62M
Payables (Quarter)	0.37M	0.20M	0.38M	0.71M	0.96M	0.38M	0.96M	2.15M	2.79M	6.44M	8.19M	7.81M	8.86M	8.69M	8.89M	9.59M	3.13M	5.18M	5.22M	4.10M
Accumulated Expenses (Quarter)	0.36M	0.00M	0.33M	0.50M	0.03M	0.81M	0.02M	0.53M	0.03M	1.99M	1.45M	0.00M	1.01M	0.61M	0.00M	0.57M	0.02M	0.22M	0.67M	0.59M
Other Accumulated Expenses (Quarter)	0.18M	0.21M	0.16M	0.13M	0.20M	0.20M	0.09M	0.08M	0.11M	0.04M	0.01M	0.01M	0.04M	0.03M	0.05M	0.06M	0.07M	0.19M	0.07M	0.07M
Short term Debt (Quarter)
Current Leases (Quarter)	0.04M	0.04M	0.06M	0.15M	0.17M	0.18M	0.18M	0.21M	0.21M	0.22M	0.24M	0.23M	0.23M	0.24M	0.23M	0.23M	0.23M	0.25M	0.26M	0.26M
Total Current Liabilities (Quarter)	0.77M	0.67M	0.77M	1.37M	2.90M	1.36M	1.84M	2.88M	4.72M	8.65M	9.88M	8.84M	10.10M	9.54M	9.77M	10.39M	4.04M	6.22M	6.14M	4.95M
Non-Current Liabilities
Capital Leases (Quarter)
Non-Current Debt (Quarter)											0.95M	0.28M	0.14M					0.93M	0.21M
Convertible Debt (Quarter)
Operating Leases (Quarter)	0.11M	0.11M	0.08M	0.89M	0.87M	0.66M	0.81M	0.60M	0.54M	0.49M	0.54M	0.49M	0.44M	0.63M	0.34M	0.52M	0.23M	0.17M	0.36M	0.30M
Other Non-Current Liabilities (Quarter)	0.16M	0.04M	0.00M	0.00M													7.30M	8.24M
Total Non-Current Liabilities (Quarter)	62.92M	57.66M	54.15M	50.88M													4.27M	7.32M
Total Liabilities (Quarter)	63.08M	57.70M	54.16M	50.88M	46.28M	2.02M	37.46M	33.62M	27.86M	9.15M	11.36M	9.61M	10.68M	9.93M	10.11M	10.68M	11.57M	15.56M	6.46M	4.99M
Shareholder's Equity
Total Debt (Quarter)											0.95M	0.28M	0.14M					0.93M	0.21M
Common Equity (Quarter)	62.05M	56.88M	53.30M	48.78M	42.70M	38.47M	34.99M	30.14M	22.60M	10.23M	4.83M	6.10M	2.91M	-1.32M	-3.86M	-6.55M	-6.08M	-9.78M	2.10M	7.74M
Liabilities and Shareholders Equity (Quarter)	63.08M	57.70M	54.16M	50.88M	46.28M	40.49M	37.46M	33.62M	27.86M	19.38M	16.19M	15.71M	13.59M	8.61M	6.25M	4.13M	5.49M	5.78M	8.59M	12.73M
Retained Earnings (Quarter)	-355.25M	-361.10M	-364.92M	-369.77M	418.09M	-380.55M	418.46M	418.51M	418.80M	-409.51M	-415.32M	-417.16M	423.71M	-426.83M	426.60M	-433.33M	-436.61M	-440.79M	-443.81M	455.31M
Preferred Shares (Quarter)	0.72M	0.71M	0.71M	0.71M	0.71M	0.70M	0.69M	0.69M	0.69M	0.69M	0.69M

Research Tools

Datasets

Plans

Developers

AIM ImmunoTech AIM Balance Sheet (2010-2026)

Research Tools

Datasets

Plans

Developers

AIM ImmunoTech AIM Balance Sheet (2010-2026)

Create an account

Sign In

Reset Password